Amy Wolf News Today

Long queues forface masks in south korea, seven people have died from coronavirus, with more than 760 infected. A man has been found guilty of murdering a pensioner by shooting him with a crossbow outside his home in anglesley last year. A town underwater Severe Weather warnings for shrewsebury, with flood leveles expected to reach their highest ever. Its 5pm our main story is that a jury in new york has started to return verdicts in the case of Harvey Weinstein, the former hollywood producer. O...

Iqirvo® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver

PARIS, FRANCE, 2 May 2024 - Ipsen , a global specialty-driven biopharmaceutical company, announced today the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024....

Press release Intended for international media and investor audiences only Ipsen delivers strong sales in the first...

Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaborationFollowing development candidate validation, Ipsen will assume responsibility...

Ipsen secures exclusive global rights for development and commercialization of STRO-003, an antibody-drug conjugate, completing the final stages of...

Ipsen secures exclusive global rights for development and commercialization of STRO-003, an antibody-drug conjugate, completing the final stages of pre-clinical developmentSTRO-003 targets ROR1, a...

Total-sales growth in FY 2023 of 6.7% at CER1 included strong sales from the growth platforms2 and good contributions from the new medicines. A core operating margin of 32.0% , based on further...

PARIS, FRANCE, 7 December 2023 - Ipsen , a global specialty-driven biopharmaceutical company, today holds its Capital Markets Day in London, U.K. “Ipsen has made significant progress since our...

Positive opinion from Committee for Medicinal Products for Human Use recommending approval of Bylvay® (odevixibat) based on Phase III ASSERT clinical-trial data in Alagille syndrome (ALGS) already received in July 2023Committee for Orphan Medicinal Products confirms a negative opinion of its review recommending not to maintain the orphan designation for Bylvay in ALGSIpsen plans to submit a new Marketing Authorisation Application for the treatment of ALGS by the end of 2023 under a new bran...